Home » Stocks » PETS

PetMed Express, Inc. (PETS)

Stock Price: $30.09 USD -0.93 (-3.00%)
Updated November 25, 4:00 PM EST - Market closed
After-hours: $30.18 +0.09 (0.30%) Nov 25, 6:50 PM

Stock Price Chart

Key Info

Market Cap 609.99M
Revenue (ttm) 305.84M
Net Income (ttm) 30.02M
Shares Out 20.27M
EPS (ttm) 1.50
PE Ratio 20.06
Forward PE 18.15
Dividend $1.12
Dividend Yield 3.72%

Stock Quote

Trading Day November 25
Last Price $30.09
Previous Close $31.02
Change ($) -0.93
Change (%) -3.00%
Day's Open 31.00
Day's Range 29.93 - 31.38
Day's Volume 353,071
52-Week Range 21.20 - 42.89

More Stats

Market Cap 609.99M
Enterprise Value 503.64M
Earnings Date (est) Jan 26, 2021
Ex-Dividend Date Nov 6, 2020
Shares Outstanding 20.27M
Float 19.50M
EPS (basic) 1.50
EPS (diluted) 1.50
FCF / Share 1.68
Dividend $1.12
Dividend Yield 3.72%
Earnings Yield 4.99%
FCF Yield 5.52%
Payout Ratio 73.30%
Shares Short 5.80M
Short Ratio 11.17
Short % of Float 29.73%
Beta 0.73
PE Ratio 20.06
Forward PE 18.15
P/FCF Ratio 18.13
PS Ratio 1.99
PB Ratio 4.32
Revenue 305.84M
Operating Income 36.35M
Net Income 30.02M
Free Cash Flow 33.65M
Net Cash 106.34M
Net Cash / Share 5.25
Gross Margin 26.56%
Operating Margin 11.89%
Profit Margin 9.80%
FCF Margin 11.00%
ROA 14.92%
ROE 22.92%
ROIC 111.00%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (3)

Buy 2
Overweight 0
Hold 0
Underweight 0
Sell 1

Analyst Consensus: Overweight

Price Target

$34.67*
(15.22% upside)
Low
25.0
Current: $30.09
High
41.0
Target: 34.67
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue284283274249235229233228238232
Revenue Growth0.25%3.51%9.88%6.18%2.31%-1.71%2.44%-4.37%2.85%-
Gross Profit81.2595.3197.8179.3176.3076.2777.6277.1280.1783.96
Operating Income30.9846.1752.1437.4832.3927.6128.2227.0126.0233.02
Net Income25.8537.7437.2823.8220.5717.4517.9717.1716.6620.87
Shares Outstanding20.0420.4620.3520.2320.1220.0219.9019.9320.6122.51
Earnings Per Share1.291.841.821.171.020.870.900.860.800.92
EPS Growth-29.89%1.1%55.56%14.71%17.24%-3.33%4.65%7.5%-13.04%-
Dividend Per Share1.081.060.850.760.720.680.660.600.530.48
Dividend Growth1.89%24.71%11.84%5.56%5.88%3.03%10%14.29%10.53%-
Operating Cash Flow38.8445.1437.3847.2021.0532.0413.5113.2920.3930.11
Capital Expenditures-2.31-0.62-0.70-10.60-20.13-0.92-0.05-0.63-0.71-0.67
Free Cash Flow36.5344.5236.6836.600.9231.1313.4612.6619.6929.44
Cash & Equivalents10410177.9458.7337.6451.2033.8433.6557.1559.78
Net Cash / Debt10410177.9458.7337.6451.2033.8433.6557.1559.78
Assets15515413511390.2882.8578.3873.1891.06106
Liabilities25.3119.7519.1119.447.087.428.169.179.889.28
Book Value13013511693.3783.2075.4470.2264.0181.1897.01
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name PetMed Express, Inc.
Country United States
Employees 214
CEO Menderes Akdag

Stock Information

Ticker Symbol PETS
Stock Exchange NASDAQ
Sector Healthcare
Industry Pharmaceutical Retailers
Unique Identifier NASDAQ: PETS

Description

PetMed Express, together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventative, flea and tick preventative, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, strollers, and other pet supplies. It sells its products through its Internet website; telephone contact center; and direct mail/print through brochures and postcards. PetMed Express, Inc. was founded in 1996 and is headquartered in Delray Beach, Florida.